|
|
Vaccine Detail
|
gp100 + Mart-1 + Mart-3 Vaccine |
| Vaccine Information |
- Vaccine Name: gp100 + Mart-1 + Mart-3 Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007481
- Type: Peptide
- Status: Research
- Antigen: gp100, MART-1, MAGE-3
- Immunization Route: Intramuscular injection (i.m.)
- Description: A vaccine that injected peptides of gp100, MART-1, MAGE-3 (Hersey et al., 2005).
|
| Host Response |
|
Human Response
- Vaccine Immune Response Type: VO_0003057
- Immune Response: GM-CSF did not increase DTH responses (Hersey et al., 2005).
|
| References |
Hersey et al., 2005: Hersey P, Menzies SW, Coventry B, Nguyen T, Farrelly M, Collins S, Hirst D, Johnson H. Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma. Cancer immunology, immunotherapy : CII. 2005; 54(3); 208-218. [PubMed: 15449035].
|
|
